Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
In this study we used stool profiling to identify intestinal bacteria and metabolites that are differentially represented in humans with colorectal cancer (CRC) compared to healthy controls to identify how microbial functions may influence CRC development. Stool samples were collected from healthy adults (n = 10) and colorectal cancer patients (n = 11) prior to colon resection surgery at the University of Colorado Health-Poudre Valley Hospital in Fort Collins, CO. The V4 region of the 16s rRNA gene was pyrosequenced and both short chain fatty acids and global stool metabolites were extracted and analyzed utilizing Gas Chromatography-Mass Spectrometry (GC-MS). There were no significant differences in the overall microbial community structure associated with the disease state, but several bacterial genera, particularly butyrate-producing species, were under-represented in the CRC samples, while a mucin-degrading species, Akkermansia muciniphila, was about 4-fold higher in CRC (p<0.01). Proportionately higher amounts of butyrate were seen in stool of healthy individuals while relative concentrations of acetate were higher in stools of CRC patients. GC-MS profiling revealed higher concentrations of amino acids in stool samples from CRC patients and higher poly and monounsaturated fatty acids and ursodeoxycholic acid, a conjugated bile acid in stool samples from healthy adults (p<0.01). Correlative analysis between the combined datasets revealed some potential relationships between stool metabolites and certain bacterial species. These associations could provide insight into microbial functions occurring in a cancer environment and will help direct future mechanistic studies. Using integrated "omics" approaches may prove a useful tool in identifying functional groups of gastrointestinal bacteria and their associated metabolites as novel therapeutic and chemopreventive targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“a few cross-sectional studies reported that patients with CRC had a lower abundance of butyrate-producing species and lower fecal levels of butyrate than controls (Table 1).97, 133–135”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [97]
In the citing paper
“Nevertheless, A. muciniphila has previously been linked to an increased burden of CRC in human and mice,25–27”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“A healthy gastrointestinal system relies on a balanced commensal biota to regulate processes such as dietary energy harvest [1], metabolism of microbial and host derived chemicals [2], and immune modulation [3].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 2×
“Prevotella was a dominant genera reported in stool from children in a rural community in Burkina Faso but absent from a cohort of Italian children, and the study authors hypothesized that Prevotella helped maximize energy harvest from a plant-based diet [29].”
BackgroundSmith, C. A., Want, E. J., O'Maille, G., Abagyan, R., & Siuzdak, G. (2006) · Analytical Chemistry · doi:10.1021/ac051437y · Cited by 5,262
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Nicholson, J. K., & Lindon, J. C. (2008) · Nature · doi:10.1038/4551054a · Cited by 1,886
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Png, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 2×
“This bacterium is a common member of the colonic microbiota and was recently shown to be reduced in irritable bowel syndrome and Crohn’s Disease [32]; however a more recent report showed increased A. muciniphila in ulcerative colitis-associated pouchitis [33].”
Background
Research works printed but not linked: 1
- J Byrd, 2004, Mucins and mucin binding proteins in colorectal cancer, Cancer and Metastasis Reviews, 23, 77, 10.1023/A:1025815113599 · DOI · Paper page
Cited by
Items 101–200 of 642
Li, F., Han, Y., Cai, X., Gu, M., Sun, J., Qi, C., Goulette, T., Song, M., Li, Z., & Xiao, H. (2020) · Food & Function · doi:10.1039/c9fo01519a · Cited by 142
Microbial markers in colorectal cancer detection and/or prognosis
Villéger, R., Lopès, A., Véziant, J., Gagnière, J., Barnich, N., Billard, E., Boucher, D., & Bonnet, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i22.2327 · Cited by 158
Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis
Wang, S., Dong, W., Liu, L., Xu, M., Wang, Y., Liu, T., Zhang, Y., Wang, B., & Cao, H. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.22999 · Cited by 139
“These bacteria are associated with increased intestinal inflammation and impaired gut barrier function.(33,34) In particular, our findings demonstrated decreased ZO‐1, claudin 3, claudin”
Rezasoltani, S., Aghdaei, H. A., Dabiri, H., Sepahi, A. A., Modarressi, M. H., & Mojarad, E. N. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.08.035 · Cited by 149
Akkermansia muciniphila: a novel functional microbe with probiotic properties
Gómez-Gallego, C., Pohl, S., Salminen, S., De Vos, W. M., & Kneifel, W. (2016) · Beneficial Microbes · doi:10.3920/bm2016.0009 · Cited by 130
Interaction between Host MicroRNAs and the Gut Microbiota in Colorectal Cancer
Yuan, C., Burns, M. B., Subramanian, S., & Blekhman, R. (2018) · mSystems · doi:10.1128/msystems.00205-17 · Cited by 143
“Studies of CRC have consistently found low fecal butyrate levels as well as a reduced relative abundance of butyrate-producing bacteria, such as members of the Firmicutes phylum (31, 37, 63).”
Lin, Y., Ma, C., Liu, C., Wang, Z., Yang, J., Liu, X., Shen, Z., & Wu, R. (2016) · Oncotarget · doi:10.18632/oncotarget.8762 · Cited by 126
“Glutaminase activity, a series of biochemical reactions by which glutamine is lysed to glutamate, is another main pillar for energy production in proliferating cells, including colonocytes [29, 39].”
BackgroundMethodAkkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice
Dingemanse, C., Belzer, C., van Hijum, S. A. F. T., Günthel, M., Salvatori, D., Dunnen, J. T. D., Kuijper, E. J., Devilee, P., de Vos, W. M., van Ommen, G. B., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv120 · Cited by 126
“A 4-fold higher abundance was found in the stool of CRC patients as compared to healthy subjects (42).”
ResultAllali, I., Delgado, S., Marron, P. I., Astudillo, A., Yeh, J. J., Ghazal, H., Amzazi, S., Keku, T., & Azcarate-Peril, M. A. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1039223 · Cited by 124
Sadrekarimi, H., Gardanova, Z. R., Bakhshesh, M., Ebrahimzadeh, F., Yaseri, A. F., Thangavelu, L. P., Hasanpoor, Z., Zadeh, F. A., & Kahrizi, M. S. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03492-7 · Cited by 143
Jans, C., Meile, L., Lacroix, C., & Stevens, M. J. A. (2014) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2014.09.017 · Cited by 134
McClements, D. J., DeLoid, G. M., Pyrgiotakis, G., Shatkin, J. A., Xiao, H., & Demokritou, P. (2016) · NanoImpact · doi:10.1016/j.impact.2016.10.002 · Cited by 131
“Likewise, while growing evidence continues to emphasize the critical role of the gut microbiome and its role in overall health (Consortium, 2012; Pflughoeft and Versalovic, 2012; Theriot et al., 2014; Turnbaugh et al., 2009; Weir et al., 2013), potential effects of iENMs on the gut microbiome remain largely unstudied…”
BackgroundHost and microbiome multi-omics integration: applications and methodologies
Wang, Q., Wang, K., Wu, W., Giannoulatou, E., Ho, J. W. K., & Li, L. (2019) · Biophysical Reviews · doi:10.1007/s12551-018-0491-7 · Cited by 134
An overview of fecal sample preparation for global metabolic profiling
Deda, O., Gika, H., Wilson, I. D., & Theodoridis, G. A. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.02.006 · Cited by 136
Bile salt hydrolase in non-enterotoxigenic Bacteroides potentiates colorectal cancer
Sun, L., Zhang, Y., Cai, J., Rimal, B., Rocha, E. R., Coleman, J. P., Zhang, C., Nichols, R. G., Luo, Y., Kim, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36089-9 · Cited by 140
Probiotics: A Promising Candidate for Management of Colorectal Cancer
Tripathy, A., Dash, J., Kancharla, S., Kolli, P., Mahajan, D., Senapati, S., & Jena, M. K. (2021) · Cancers · doi:10.3390/cancers13133178 · Cited by 133
Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice
Mendes, M. C. S., Paulino, D. S., Brambilla, S. R., Camargo, J. A., Persinoti, G. F., & Carvalheira, J. B. C. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i18.1995 · Cited by 116
Sheflin, A. M., Borresen, E. C., Kirkwood, J. S., Boot, C. M., Whitney, A. K., Lu, S., Brown, R. J., Broeckling, C. D., Ryan, E. P., & Weir, T. L. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500905 · Cited by 113
“5) as previously described [16] and spiked with 1 mM of ethylbutyric acid that was used as an internal standard.”
Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Panel on Nutrition, N. F. A. F. A. (., Turck, D., Bohn, T., Castenmiller, J., De Henauw, S., Hirsch‐Ernst, K. I., Maciuk, A., Mangelsdorf, I., McArdle, H. J., Naska, A., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6780 · Cited by 110
“, 2019), colorectal cancer (Weir et al., 2013; Zackular et al., 2013; Baxter et al., 2014; Wang et al., 2020), multiple sclerosis (Jangi et al.”
BackgroundThe Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real?
Thomas, R. M., & Jobin, C. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.07.005 · Cited by 110
“It has been demonstrated that a correlation may exist between low-butyrate and high-acetate levels in patients with adenomatous polyp formation and colon cancer [71,72].”
BackgroundThe Dynamic Changes of Gut Microbiota in Muc2 Deficient Mice
Wu, M., Wu, Y., Li, J., Bao, Y., Guo, Y., & Yang, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092809 · Cited by 116
“Numerous studies have suggested that butyrate-producing bacteria is beneficial to intestinal health, and the bacteria was reduced in CRC patients [23,42] and in mice with CRC induced by AOM/DSS or 1,2-dimethylhydrazine (1,2-DMH) [12,27].”
BackgroundWang, F., Cai, K., Xiao, Q., He, L., Xie, L., & Liu, Z. (2021) · Journal of Cancer · doi:10.7150/jca.63578 · Cited by 121
“muciniphila in CRC patients was 4 times higher than that of healthy subjects [10].”
BackgroundAssociation of dietary fibre intake and gut microbiota in adults
Lin, D., Peters, B. A., Friedlander, C., Freiman, H. J., Goedert, J. J., Sinha, R., Miller, G., Bernstein, M. A., Hayes, R. B., & Ahn, J. (2018) · British Journal of Nutrition · doi:10.1017/s0007114518002465 · Cited by 109
Zhang, Z., Cao, H., Song, N., Zhang, L., Cao, Y., & Tai, J. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111237 · Cited by 109
Avuthu, N., & Guda, C. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00013-22 · Cited by 123
“Interestingly amino acids valine, leucine, isoleucine, and phenylalanine showed enrichment in CRC than controls, which has been previously observed in CRC (56, 57).”
ResultGut commensals and their metabolites in health and disease
Krishnamurthy, H. K., Pereira, M., Bosco, J., George, J., Jayaraman, V., Krishna, K., Wang, T., Bei, K., & Rajasekaran, J. J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1244293 · Cited by 124
Huang, G., Khan, I., Li, X., Chen, L., Leong, W., Ho, L. T., & Hsiao, W. L. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-12644-5 · Cited by 112
Metabolite and Microbiome Interplay in Cancer Immunotherapy
Johnson, C. H., Spilker, M. E., Goetz, L. H., Peterson, S. N., & Siuzdak, G. E. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0309 · Cited by 114
“A recent study focused on colorectal cancer integrated microbiome (16S rRNA) and metabolomics data to demonstrate that the microbial composition was similar between healthy and colorectal patients but that short chain fatty acids andothermetabolites differed between the two groups (44).”
BackgroundWu, M., Wu, Y., Deng, B., Li, J., Cao, H., Qu, Y., Qian, X., & Zhong, G. (2016) · Oncotarget · doi:10.18632/oncotarget.13347 · Cited by 109
“Previous studies have indicated that the abundance of Akkermansia was positively correlated with colonic tumor multiplicity and size [37, 46], and that the abundance of Akkermansia in the gut was significantly increased in CRC patients [39, 47] Akkermansia municiphila is a component of the healthy gut microbiome and a…”
BackgroundLeBlanc, A. D. M. D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16518 · Cited by 101
Akkermansia muciniphila plays critical roles in host health
Zhao, Q., Yu, J., Hao, Y., Zhou, H., Hu, Y., Zhang, C., Zheng, H., Wang, X., Zeng, F., Hu, J., et al. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2037506 · Cited by 111
“The abundance of A. muciniphila is increased in the faeces of patients with irritable bowel syndrome (Lo Presti et al. 2019) and those with CRC (Weir et al. 2013; Wang et al. 2017).”
BackgroundInfluentialAlvandi, E., Wong, W. K. M., Joglekar, M. V., Spring, K. J., & Hardikar, A. A. (2022) · BMC Medicine · doi:10.1186/s12916-022-02529-4 · Cited by 101
“In addition to the SCFAs assessed in this systematic review, other metabolites such as bile acids were also measured in six of the selected studies [20, 30, 32, 35, 36, 39].”
BackgroundSpace-type radiation induces multimodal responses in the mouse gut microbiome and metabolome
Casero, D., Gill, K., Sridharan, V., Koturbash, I., Nelson, G., Hauer-Jensen, M., Boerma, M., Braun, J., & Cheema, A. K. (2017) · Microbiome · doi:10.1186/s40168-017-0325-z · Cited by 99
“In agreement with our modeling results, the overabundance on Phenylalanine has been previously associated with the activity of Clostridiales species [42].”
ResultWang, Y., Guo, Y., Chen, H., Wei, H., & Wan, C. (2018) · Canadian Journal of Microbiology · doi:10.1139/cjm-2017-0716 · Cited by 105
Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?
Lei, W., Cheng, Y., Gao, J., Liu, X., Shao, L., Kong, Q., Zheng, N., Ling, Z., & Hu, W. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1224155 · Cited by 112
Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer
Santhanam, S., Alvarado, D. M., & Ciorba, M. A. (2015) · Translational research · doi:10.1016/j.trsl.2015.07.003 · Cited by 106
Guerrero-Preston, R., White, J. R., Godoy-Vitorino, F., Rodríguez-Hilario, A., Navarro, K., González, H., Michailidi, C., Jedlicka, A., Canapp, S., Bondy, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20677 · Cited by 97
Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer
Clos‐Garcia, M., García‐Etxebarria, K., Alonso, C., Iruarrizaga‐Lejarreta, M., D’Amato, M., Crespo, A., Iglesias, Á., Cubiella, J., Bujanda, L., & Falcón‐Pérez, J. M. (2020) · Cancers · doi:10.2139/ssrn.3520024 · Cited by 109
Moreno, F. J., Corzo, N., Montilla, A., Villamiel, M., & Olano, A. (2017) · Current Opinion in Food Science · doi:10.1016/j.cofs.2017.02.009 · Cited by 108
Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression
Torres-Maravilla, E., Boucard, A.-S., Mohseni, A. H., Taghinezhad-S, S., Cortes-Perez, N. G., & Bermúdez-Humarán, L. G. (2021) · Microorganisms · doi:10.3390/microorganisms9051021 · Cited by 96
“These changes in the microbiome and metagenome coincide with a decrease in butyrate concentration in CRC patients [41,69].”
BackgroundRole of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
Pellegrino, A., Coppola, G., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Nutrients · doi:10.3390/nu15081815 · Cited by 112
“, this observation can be related to an increased substrate availability rather than to a detrimental role of this bacterium, considering the overexpression of MUC1 and MUC5AC in CRCs [78].”
BackgroundTian, M., Li, D., Ma, C., Feng, Y., Hu, X., & Chen, F. (2021) · Nutrients · doi:10.3390/nu13030846 · Cited by 103
“muciniphila increased in DSS-induced colitis mice and colorectal cancer patients and was highly positively correlated with the severity of colitis [27,44].”
BackgroundMicrobiota-driven mechanisms at different stages of cancer development
Ivleva, E., & Grivennikov, S. I. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100829 · Cited by 103
Jain, A., Li, X. H., & Chen, W. N. (2019) · Scientific Reports · doi:10.1038/s41598-019-45640-y · Cited by 108
Exercise is a Novel Promoter of Intestinal Health and Microbial Diversity
Campbell, S. C., & Wisniewski, P. J. (2017) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000096 · Cited by 88
“Of note, butyrate is known to influence proliferation, differentiation, and survival of colonocytes and is found to be higher in healthy individuals compared with patients with colon cancer (44).”
BackgroundResultMicrobiota and gastrointestinal cancer
Weng, M., Chiu, Y., Wei, P., Chiang, C.-W., Fang, H., & Wei, S. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.01.002 · Cited by 94
Inamura, K., Hamada, T., Bullman, S., Ugai, T., Yachida, S., & Ogino, S. (2022) · Gut · doi:10.1136/gutjnl-2022-327209 · Cited by 100
Microbiome distinctions between the CRC carcinogenic pathways
DeDecker, L. C., Coppedge, B., Avelar‐Barragan, J., Karnes, W. E., & Whiteson, K. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1854641 · Cited by 93
Impact of antibiotic exposure on the risk of colorectal cancer: ANTIBIOTIC EXPOSURE AND CRC RISK
Boursi, B., Haynes, K., Mamtani, R., & Yang, Y.-X. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3765 · Cited by 89
Bussche, J. V., Marzorati, M., Laukens, D., & Vanhaecke, L. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02688 · Cited by 99
Gut microbiome of Moroccan colorectal cancer patients
Allali, I., Boukhatem, N., Bouguenouch, L., Hardi, H., Boudouaya, H. A., Cadenas, M. B., Ouldim, K., Amzazi, S., Azcárate-Peril, M. A., & Ghazal, H. (2018) · Medical Microbiology and Immunology · doi:10.1007/s00430-018-0542-5 · Cited by 94
Impact of a 3-Months Vegetarian Diet on the Gut Microbiota and Immune Repertoire
Zhang, C., Björkman, A., Cai, K., Liu, G., Wang, C., Li, Y., Xia, H., Sun, L., Kristiansen, K., Wang, J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00908 · Cited by 87
“This species belongs to a group of bacteria that grow in the presence of bile (38) and has been reported to be associated with colon cancer (39).”
BackgroundEnvironmental Influences in the Etiology of Colorectal Cancer: the Premise of Metabolomics
Rattray, N. J. W., Charkoftaki, G., Rattray, Z., Hansen, J. E., Vasiliou, V., & Johnson, C. H. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0088-z · Cited by 98
Sheflin, A., Borresen, E., Wdowik, M., Rao, S., Brown, R., Heuberger, A., Broeckling, C., Weir, T., & Ryan, E. (2015) · Nutrients · doi:10.3390/nu7021282 · Cited by 85
“Lyophilized stool metabolites were extracted using 80:20 MeOH:H2O and detected using GC-MS, as described previously [25].”
MethodCozzolino, A., Vergalito, F., Tremonte, P., Iorizzo, M., Lombardi, S. J., Sorrentino, E., Luongo, D., Coppola, R., Di Marco, R., & Succi, M. (2020) · Microorganisms · doi:10.3390/microorganisms8020189 · Cited by 84
“[10] observed that mucin-degrading bacteria, including A.”
Jayachandran, M., Chung, S. S. M., & Xu, B. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1632789 · Cited by 89
“…results demonstrated no significant difference in the total bacterial community, but the population of the butyrate-producing bacteria reduced and that of A. muciniphila, increased 4 folds in CRC samples (Weir et al. 2013), indicating that A. muciniphila plays an important role in CRC development.”
BackgroundThe Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
Smet, A., Kupčinskas, J., Link, A., Hold, G. L., & Bornschein, J. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.013 · Cited by 94
Gestational Diabetes Is Uniquely Associated With Altered Early Seeding of the Infant Gut Microbiota
Soderborg, T. K., Carpenter, C. M., Janssen, R. C., Weir, T. L., Robertson, C. E., Ir, D., Young, B. E., Krebs, N. F., Hernandez, T. L., Barbour, L. A., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.603021 · Cited by 87
“Supernatantwas collected, re-centrifuged, and stored at−80°Cuntil analysis, as previously (12, 45).”
MethodBlakeney, B. A., Crowe, M. S., Mahavadi, S., Murthy, K. S., & Grider, J. R. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5417-5 · Cited by 85
Manor, O., Levy, R., & Borenstein, E. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.021 · Cited by 81
“Complexity, especially in biology, is a product not simply of the number of parts a system is composed of, but rather of the complex and often nonlinear way in which these parts interact (Weaver, 1948).”
The opportunistic nature of gut commensal microbiota
Dey, P., & Chaudhuri, S. R. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2133987 · Cited by 94
“For instance, despite the popularity of A. muciniphila as a beneficial commensal, several recent studies have reported its association with various types of cancers (Weir et al. 2013; Dingemanse et al. 2015; Howe et al. 2018; Huang et al. 2021).”
BackgroundForster, G. M., Stockman, J. A., Noyes, N. R., Heuberger, A. L., Broeckling, C. D., Bantle, C. M., & Ryan, E. P. (2018) · Topics in companion animal medicine · doi:10.1053/j.tcam.2018.08.003 · Cited by 101
The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies
Huybrechts, I., Zouiouich, S., Loobuyck, A., Vandenbulcke, Z., Vogtmann, E., Pisanu, S., Iguacel, I., Scalbert, A., Indave, I., Smelov, V., et al. (2020) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0288 · Cited by 80
“While findings on alpha diversity were inconsistent (2, 25, 52, 84, 85, 87, 89, 90, 92, 96, 97, 100, 101, 108, 110, 113, 114), five studies on colorectal cancer found significant results for beta diversity (84–86, 98, 100).”
BackgroundIllescas, O., Rodríguez‐Sosa, M., & Gariboldi, M. (2021) · Nutrients · doi:10.3390/nu13072234 · Cited by 98
Wang, K., Wu, W., Wang, Q., Yang, L., Bian, X., Jiang, X., Lv, L., Yan, R., Xia, J., Han, S., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.932047 · Cited by 96
“muciniphila with increased tumor burden, and even the harmful effects of this bacterium on the progression of colonic tumorigenesis (Weir et al., 2013; Baxter et al., 2014; Wang et al., 2022), while some studies reported a protective potential of A.”
BackgroundRojo, D., Hevia, A., Bargiela, R., López, P., Cuervo, A., González, S., Suárez, A., Sánchez, B., Martínez-Martínez, M., Milani, C., et al. (2015) · Scientific Reports · doi:10.1038/srep08310 · Cited by 79
A systematic review of microbiome-derived biomarkers for early colorectal cancer detection
Zwezerijnen-Jiwa, F. H., Sivov, H., Paizs, P., Zafeiropoulou, K., & Kinross, J. K. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100868 · Cited by 93
Sample preparation optimization in fecal metabolic profiling
Deda, O., Chatziioannou, A. C., Fasoula, S., Palachanis, D., Raikos, Ν., Theodoridis, G. A., & Gika, H. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.06.047 · Cited by 84
Niccolai, E., Russo, E., Baldi, S., Ricci, F., Nannini, G., Pedone, M., Stingo, F. C., Taddei, A., Ringressi, M. N., Bechi, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573158 · Cited by 87
“Consistent with Weir et al (96), we find that Ruminococcus spp.”
High-resolution characterization of the human microbiome
Noecker, C., McNally, C. P., Eng, A., & Borenstein, E. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.012 · Cited by 79
Mima, K., Ogino, S., Nakagawa, S., Sawayama, H., Kinoshita, K., Krashima, R., Ishimoto, T., Imai, K., Iwatsuki, M., Hashimoto, D., et al. (2017) · Surgical Oncology · doi:10.1016/j.suronc.2017.07.011 · Cited by 85
Wang, X., Wang, J. P., Rao, B., & Deng, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4367 · Cited by 81
“Mucin (MUC)1 and MUC5AC are often overexpressed in colorectal cancer tissues, which is attributed to the increased stability of intestinal tissue matrix due to an abundance of Akkermansia spp (21,22) .”
RetractedMicrobial metabolites in colorectal tumorigenesis and cancer therapy
Liu, Y., Lau, H. C.-H., & Yu, J. Q. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2203968 · Cited by 89
Metabolomics of fecal samples: A practical consideration
Matysik, S., Roy, C. I. L., Liebisch, G., & Claus, S. P. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.05.011 · Cited by 88
“224 M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT 11 Using a similar methodology, Weir et al. analyzed the fecal metabolome in CRC 225 patients (Weir et al., 2013).”
Rombouts, C., Hemeryck, L., HECKE, T. V., SMET, S. D., Vos, W. H. D., & Vanhaecke, L. (2017) · Scientific Reports · doi:10.1038/srep42514 · Cited by 80
Ullah, I., Yang, L., Yin, F., Sun, Y., Li, X., Li, J., & Wang, X. (2022) · Cancers · doi:10.3390/cancers14225545 · Cited by 91
Impact of demographics on human gut microbial diversity in a US Midwest population
Chen, J., Ryu, E., Hathcock, M., Ballman, K., Chia, N., Olson, J. E., & Nelson, H. (2016) · PeerJ · doi:10.7717/peerj.1514 · Cited by 74
“Megamonas species are associated with colon cancer (Weir et al., 2013), but they are also associated with normal glucose tolerance 0.”
BackgroundInfluentialZhang, J., Lacroix, C., Wortmann, E., Ruscheweyh, H., Sunagawa, S., Sturla, S. J., & Schwab, C. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1483-x · Cited by 76
Commensal Obligate Anaerobic Bacteria and Health: Production, Storage, and Delivery Strategies
Andrade, J. C., Almeida, D., Domingos, M., Seabra, C. L., Machado, D., Freitas, A. C., & Gomes, A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00550 · Cited by 85
“muciniphila was identified in numbers about 4-fold higher in colorectal cancer patients when compared to healthy subjects (Weir et al., 2013).”
BackgroundGhaffari, S., Abbasi, A., Somi, M. H., Moaddab, S. Y., Nikniaz, L., Kafil, H. S., & Leylabadlo, H. E. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2045894 · Cited by 88
“For example, a study by Weir et al. showed that the mucin-degrading bacteria , A. muciniphila , were present in a significantly greater proportion in the feces of colon cancer patients in comparison with healthy controls (Weir et al. 2013).”
ResultNon-invasive fecal metabonomic detection of colorectal cancer
Phua, L. C., Chue, X. P., Koh, P. K., Cheah, P. Y., Ho, H. K., & Chan, E. C. Y. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.27625 · Cited by 75
“also described the GC/MS-based fecal metabonomic profiling of CRC but the influence of blood in stool was not considered in the elucidation of marker metabolites.(35) In our study, non-blood-related fecal marker metabolites were extracted from model 2 constructed using fecal samples that do not contain gross levels of…”
MethodMicrobe-based therapies for colorectal cancer: Advantages and limitations
Saeed, M., Shoaib, A., Kandimalla, R., Javed, S., Almatroudi, A., Gupta, R. C., & Aqil, F. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.018 · Cited by 75
Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review
Erben, V., Bhardwaj, M., Schrotz‐King, P., & Brenner, H. (2018) · Cancers · doi:10.3390/cancers10080246 · Cited by 73
“It could be shown that the gut microbiota is different in patients with CRC compared to healthy controls [59,67] and is directly involved in carcinoma development [68,69].”
BackgroundThe Role of the Microbiome in Gastrointestinal Cancer
Wroblewski, L. E., Peek, R. M., & Coburn, L. A. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.04.010 · Cited by 85
Noecker, C. A., Chiu, H.-C., McNally, C. P., & Borenstein, E. (2019) · mSystems · doi:10.1128/msystems.00579-19 · Cited by 69
Role of gut microbiota in epigenetic regulation of colorectal Cancer
Zhao, Y., Wang, C., & Goel, A. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188490 · Cited by 77
Osman, M. A., Neoh, H., Mutalib, N. A., Chin, S., & Jamal, R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00767 · Cited by 79
“1(Baxter et al., 2016) 2(Ahn et al., 2013; Sinha et al., 2016) 3 (Weir et al., 2013) 4(Burns et al., 2015) 5(Allali et al., 2015) 6(Thomas et al., 2016) 7(Marchesi et al., 2011) 8(Flemer et al., 2017) 9(Mira-Pascual et al., 2015) 10(Zackular et al., 2014) 11(Kostic et al., 2012) 12(Sobhani et al.,…”
MethodFernández, J., Ledesma, E., Monte, J., Millán, E., Costa, P., de la Fuente, V. G., García, M. T. F., Martínez‐Camblor, P., Villar, C. J., & Lombó, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-51437-w · Cited by 70
Grenda, A., Iwan, E., Chmielewska, I., Krawczyk, P. A., Giza, A., Bomba, A., Frąk, M., Rolska-Kopińska, A., Szczyrek, M., Kieszko, R., et al. (2022) · AMB Express · doi:10.1186/s13568-022-01428-4 · Cited by 71
“In colorectal cancer patients, it is described as one of the possible causes of this disease, due to its ability to degrade mucin in the intestine, causing inflammation and subsequent cancer (Weir et al. 2013; Sanapareddy et al. 2013).”
BackgroundShaping functional gut microbiota using dietary bioactives to reduce colon cancer risk
Seidel, D., Azcárate-Peril, M. A., Chapkin, R. S., & Turner, N. D. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.009 · Cited by 69
Inamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.006 · Cited by 63
Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota
Ericsson, A. C., Akter, S., Hanson, M. M., Busi, S. B., Parker, T. W., Schehr, R., Hankins, M. A., Ahner, C. E., Davis, J. W., Franklin, C. L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5604 · Cited by 65
“copri in the stool of healthy controls relative to samples from 10 patients recently diagnosed with CRC [30].”
BackgroundAggarwal, V., Sunder, S., & Verma, S. R. (2022) · Folia Microbiologica · doi:10.1007/s12223-022-00973-6 · Cited by 71
“Colorectal cancer Elevated 16S rRNA sequencing Faeces (Weir et al. 2013)”
BackgroundCurrent State and Challenges of the Global Outcomes of Dental Caries Research in the Meta-Omics Era
Moussa, D. G., Ahmad, P., Mansour, T. A., & Siqueira, W. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.887907 · Cited by 81
Relationship between intestinal microbiota and colorectal cancer
Çıpe, G., İdiz, U. O., Fırat, Y. D., & Bektaşoğlu, H. K. (2015) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v7.i10.233 · Cited by 70
Impact of microbiota in colorectal carcinogenesis: lessons from experimental models
Yu, L. C., Wei, S., & Ni, Y. (2018) · Intestinal Research · doi:10.5217/ir.2018.16.3.346 · Cited by 67
“Under the Bacteroidetes phylum, enrichment of genera of Porphyromonas and Prevotella was reported in stool samples of CRC patients compared to healthy volunteers.(44,45) Conflicting results were shown for the Bacteroides genus; increased percentage were reported in CRC patients in some studies,(35,43) while others fou…”
BackgroundResultInfluentialmbImpute: an accurate and robust imputation method for microbiome data
Jiang, R., Li, W. V., & Li, J. J. (2021) · Genome biology · doi:10.1186/s13059-021-02400-4 · Cited by 69
Volatile Organic Compounds as Novel Markers for the Detection of Bacterial Infections
Zhang, L. (2014) · Clinical Microbiology Open Access · doi:10.4172/2327-5073.1000151 · Cited by 62
“Fecal metabolites profiling along with fecal microbiota profile analysis have been employed to find the valuable markers for diagnosis of some non-infectious disorders such as autism, colorectal cancer, chronic gastrointestinal disease, celiac disease, nonalcoholic fatty liver disease and necrotising enterocolitis [55…”
BackgroundResultThe yin and yang of leukotriene B 4 mediated inflammation in cancer
Jala, V. R., Bodduluri, S. R., Satpathy, S. R., Chheda, Z. S., Sharma, R. K., & Haribabu, B. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.005 · Cited by 62
“muciniphila (Verrucomicrobia phylum) is a mucin degrading bacteria present in the human intestines [96–98], and was reported to be present at increased levels in colon cancer patients [99], ulcerative colitis-associated pouchitis [100] compared to healthy individuals.”
The Application of Metabolomics in Recent Colorectal Cancer Studies: A State-of-the-Art Review
Gold, A., Choueiry, F., Jin, N. Y., Mo, X. M., & Zhu, J. (2022) · Cancers · doi:10.3390/cancers14030725 · Cited by 65
“We identified six studies that employed metabolomics to recognize many metabolites associated with CRC incidence and correlated them with corresponding 16S ribosomal RNA gene analyses of gut bacteria genera [33,34,37,44,46,48].”
BackgroundMethodInfluential
Metadata
- Authors
- Weir, T. L., Manter, D. K., Sheflin, A. M., Barnett, B. A., Heuberger, A. L., & Ryan, E. P.
- Affiliations
- Colorado State University (US)
- Agricultural Research Service (US)
- Corresponding author
- Weir, Tiffany L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-08-06
- Volume
- 8
- Issue
- 8
- Pages
- e70803
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3735522
- OpenAlex
- W2115450300
- Cited by
- 642
- References
- 48
- Citations by year
- 2026: 15 · 2025: 40 · 2024: 37 · 2023: 60 · 2022: 66 · 2021: 67 · 2020: 67 · 2019: 74 · 2018: 58 · 2017: 53 · 2016: 54 · 2015: 29 · 2014: 21 · 2013: 1
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Cancer Institute (R03CA150070)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- colorectal cancer, gut microbiota, Akkermansia muciniphila, butyrate, short-chain fatty acids, mucin degradation, ursodeoxycholic acid, bile acids, amino acids, polyunsaturated fatty acids, monounsaturated fatty acids, acetate, 16S rRNA gene, chemoprevention
- MeSH terms
- Adult, Aged, Aged, 80 and over, Carcinoma in Situ, Feces, Female, Health, Humans, Male, Middle Aged, Colorectal Neoplasms, Case-Control Studies, Metabolome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.